IDXX 8-K 2026-11-02

IDEXX LABORATORIES INC /DE (IDXX) 8-K dated 2026-11-02 — accession 0001104659-26-120892.

IDEXX LABORATORIES INC /DE (IDXX) is a diagnostics & research company listed on NASDAQ.

IDXX: SECURITIES AND EXCHANGE COMMISSION

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported IDXX revenue for 2025-12-31 was $4.30B. Net income was $1.06B. Revenue was up 10.4% from 2024-12-31 to 2025-12-31. IDXX currently screens at market cap $43.08B and trailing P/E 38.7.

Not investment advice. The IDXX SEC hub lists recent forms. The stock page is the research view.